NCT04581044

Brief Summary

COVID-19 had a major impact on dermatology practice globally with special emphasis on chronic diseases e.g. psoriasis. The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis management. This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian dermatologists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
197

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2020

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2020

Completed
Last Updated

January 14, 2022

Status Verified

December 1, 2021

Enrollment Period

1 month

First QC Date

October 6, 2020

Last Update Submit

December 31, 2021

Conditions

PsoriasisCovid19

Keywords

PsoriasiscoronavirusSars-Cov-2

Outcome Measures

Primary Outcomes (2)

  • Questionnaire to assess 1) Prescription pattern for Psoriasis patients during COVID-19 2) Management pattern for Psoriasis patients during COVID-19

    2-4 weeks

  • Questionnaire to assess 1) Impact of COVID-19 on the course of psoriasis in patients 2) Impact of COVID-19 on the psoriasis patients behaviour

    2-4 weeks

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Egyptian Dermatologists

You may qualify if:

  • Egyptian Dermatologists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mona El-Kalioby

Cairo, 11351, Egypt

Location

MeSH Terms

Conditions

PsoriasisCOVID-19Coronavirus Infections

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 9, 2020

Study Start

September 17, 2020

Primary Completion

October 23, 2020

Study Completion

October 23, 2020

Last Updated

January 14, 2022

Record last verified: 2021-12

Locations

EG(1)